Patent ID: 6503897
Filing Date: 2003-01-07
Classification: A61P,C07D

Abstract:
A compound selected from the group consisting of:2R-[(Formyl-hydroxy-amino)-methyl]-hexanoic acid (4,7,7-trimethyl-5-oxo-[1,4]thiazepan-6R-yl) amide; 2-[(Formyl-hydroxy-amino)-methyl]-hexanoic acid (5,5-dimethyl-7-oxo-[1,4]oxathiepan-6-yl)-amide; 2-[(Formyl-hydroxy-amino)-methyl]-hexanoic acid (7,7-dimethyl-5-oxo-octahydro-8-thia-4a-aza-benzocyclohepten-6-yl)-amide; 2-[(Formyl-hydroxy-amino)-methyl]-hexanoic acid (4-ethyl-7,7-dimethyl-5-oxo-[1,4]thiazapan-6-yl)-amide; 2-[(Formyl-hydroxy-amino)-methyl]-hexanoic acid (4-propyl-7,7-dimethyl-5-oxo-[1,4]thiazapan-6-yl)-amide; 2R-[(formyl-hydroxy-amino)-methyl]-hexanoic acid (1-benzyl-2-oxo-piperidin-3S-yl) amide; 2R-[(Formyl-hydroxy-amino)-methyl]-hexanoic acid (2-oxo-azepan-3S-yl)-amide; 2R-[(formyl-hydroxy-amino)-methyl]-hexanoic acid (2,9-dioxo-1,8 diaza-cyclotetradec- 3S-yl)-amide; 2R-[(formyl-hydroxy-amino)-methyl]-hexanoic acid (2-oxo-azacyclotridec-3R,S-yl)-amide; and 2R-[(Formyl-hydroxy-amino)-methyl]-hexanoic acid [4-methyl-5-oxo-1-(4-trifluoromethyl-benzenesufonyl)-[1,4]diazepan6S-yl]-amide.